Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ledrogon Jun 15, 2018 8:28am

237 Views

Post# 28176594

RE:RE:1 million + delivery failures?

I realized I didn't answer your question about whether or not I'm still expecting a bear attack....

Frankly, I'm thinking its less likely now than before....not since seeing what I take to be an indication of over 1 million delivery failures. I'll have a better idea of where my thinking is at when the updated short number comes out....I'm guessing shortdata.ca will have numbers out this evening or tomorrow, and then stockwatch should have their update by Wed or Thurs.

Happy Friday....here's hoping its a good one.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions